Charity Abelardo

With over 12 years in Pharmaceutical Drug Development, Charity Abelardo, has obtained broad exposure to and understanding of the multiple disciplines and functions critical to the drug development process. Ms. Abelardo has been providing independent consultant services to the Pharmaceutical and Life Science industry since 2006. Ms. Abelardo is an effective communicator experienced in direct health authority interaction and has extensive experience preparing INDs, NDAs, CTAs and MAAs. She has worked with Dermatology OTC and Rx Products, Cosmetics, Antiviral and Antibacterial Drug Products, Neurological Drug Products, as well as within the Autoimmune, Cardiovascular, Oncology, and Pulmonary therapeutic areas. Ms. Abelardo is proactive in the planning and implementation of regulatory strategies and maintains a strong record of accomplishment in managing changing priorities while retaining high quality and compliance.

Ms. Abelardo began her career in Regulatory Affairs in 1996 with Alliance Pharmaceutical Corporation. Over the next 3 years she worked to obtain an essential foundation for a successful career in Regulatory Affairs. Thereafter, in 1998, Ms. Abelardo joined Agouron Pharmaceuticals, Inc and held various Regulatory Affairs positions within the Research and Development and Commercial Divisions following the acquisition of Agouron by Warner-Lambert and by Pfizer. Most recently, over the last 7 years, Ms. Abelardo served La Jolla Pharmaceutical Company, holding various management positions of increasing levels of responsibility. Ms. Abelardo has an educational background in Business Management and has held the US Regulatory Affairs Certification since 2001. She is an active member of the Regulatory Affairs Professional Society (RAPS), The Organisation for Professionals in Regulatory Affairs (TOPRA), and Drug Information Association (DIA).